Correlation Between Cybin and Capricor Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cybin and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cybin and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cybin Inc and Capricor Therapeutics, you can compare the effects of market volatilities on Cybin and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cybin with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cybin and Capricor Therapeutics.

Diversification Opportunities for Cybin and Capricor Therapeutics

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cybin and Capricor is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cybin Inc and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Cybin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cybin Inc are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Cybin i.e., Cybin and Capricor Therapeutics go up and down completely randomly.

Pair Corralation between Cybin and Capricor Therapeutics

Given the investment horizon of 90 days Cybin is expected to generate 4.5 times less return on investment than Capricor Therapeutics. But when comparing it to its historical volatility, Cybin Inc is 1.14 times less risky than Capricor Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  350.00  in Capricor Therapeutics on September 18, 2024 and sell it today you would earn a total of  1,038  from holding Capricor Therapeutics or generate 296.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cybin Inc  vs.  Capricor Therapeutics

 Performance 
       Timeline  
Cybin Inc 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cybin Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental drivers, Cybin displayed solid returns over the last few months and may actually be approaching a breakup point.
Capricor Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Cybin and Capricor Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cybin and Capricor Therapeutics

The main advantage of trading using opposite Cybin and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cybin position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.
The idea behind Cybin Inc and Capricor Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments